Censo Biotechnologies Revenue and Competitors

Easter Bush,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Censo Biotechnologies's estimated annual revenue is currently $775k per year.(i)
  • Censo Biotechnologies's estimated revenue per employee is $155,000

Employee Data

  • Censo Biotechnologies has 5 Employees.(i)
  • Censo Biotechnologies grew their employee count by 0% last year.

Censo Biotechnologies's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Censo Biotechnologies?

Censo Bio is a leader in creating relevant, customizable human neurological and inflammatory disease models with induced pluripotent stem cells (iPSC). With deep expertise in neuroscience, immunology, stem cell biology and gene editing, Censo Biotechnologies specializes in model and assay design for drug discovery. Censo has the ability to select or engineer the desired human genetic background by creating iPSC from patient samples or using CRISPR for gene editing. We have established robust, propriety differentiation protocols for sensory and excitatory cortical neurons, astrocytes, microglia, macrophages, monocytes, and dendritic cells as well as co-cultures. We also offer a host of phenotypic and screening assays which can be customized or developed specifically for your needs. We employ rigorous QC measures and maintain comprehensive SOPs and documentation. Censo's scientists will work closely with you to create the most relevant models and assays for your project.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Censo Biotechnologies News

2022-03-22 - Epithelial Cell Culture Media Market to exceed USD ...

In Sep-2020 – Axol Bioscience and Censo Biotechnologies Announce Merger. The new entity would become a global leader in the iPSC-based...